Teva Drops Inhaler Patent Infringement Lawsuit Against Amneal
Teva Pharmaceutical Industries Ltd. has decided to end its legal battle against Amneal Pharmaceuticals of New York LLC and its affiliates...
Daily reporting, analysis, and legal-market coverage across patents, trademarks, copyright, licensing, disputes, and policy.
5 articles published on this day, newest first.
Teva Pharmaceutical Industries Ltd. has decided to end its legal battle against Amneal Pharmaceuticals of New York LLC and its affiliates...
SkyWater Technology Secures Access to Silicon-Proven Mixed-Signal ASIC Design IP SkyWater Technology has recently announced a significant milestone in the semiconduc...
Maroun S. Mourad to Lead Intellectual Property Segment at Clarivate Plc LONDON, July 30, 2025 - Clarivate Plc, a global provider of transformati...
As the first summer of the second Trump administration unfolds, government agencies are facing budget cuts, personnel reductions, attrition, hi...
In a recent development, 18 Republican Senators have penned a letter to U.S....
Get Top 5 IP News Today, weekly editorial roundups, and region-aware updates tailored to your practice.
Teva Pharmaceutical Industries Ltd. has decided to end its legal battle against Amneal Pharmaceuticals of New York LLC and its affiliates...
SkyWater Technology Secures Access to Silicon-Proven Mixed-Signal ASIC Design IP SkyWater Technology has recently announced a significant milestone in the semiconduc...
Maroun S. Mourad to Lead Intellectual Property Segment at Clarivate Plc LONDON, July 30, 2025 - Clarivate Plc, a global provider of transformati...
As the first summer of the second Trump administration unfolds, government agencies are facing budget cuts, personnel reductions, attrition, hi...
In a recent development, 18 Republican Senators have penned a letter to U.S....
Practical trademarks context for IP teams tracking Trademarks, Tether, Korean.
IIPLA reviews the trademarks implications of Trademarks, Tether, Korean, with practical notes for global IP teams monitoring risk, enforcement, licensing, and portfolio strategy.